Linde Plc (LIN) concluded trading on Thursday at a closing price of $466.16, with 3.07 million shares of worth about $1.43 billion changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -1.66% during that period and on March 06, 2025 the price saw a loss of about -0.45%. Currently the company’s common shares owned by public are about 472.91M shares, out of which, 469.43M shares are available for trading.
Stock saw a price change of 1.28% in past 5 days and over the past one month there was a price change of 2.50%. Year-to-date (YTD), LIN shares are showing a performance of 11.34% which increased to 2.32% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $410.69 but also hit the highest price of $487.49 during that period. The average intraday trading volume for Linde Plc shares is 2.36 million. The stock is currently trading 0.96% above its 20-day simple moving average (SMA20), while that difference is up 5.18% for SMA50 and it goes to 3.35% higher than SMA200.
Linde Plc (NASDAQ: LIN) currently have 472.91M outstanding shares and institutions hold larger chunk of about 83.91% of that.
The stock has a current market capitalization of $220.45B and its 3Y-monthly beta is at 0.97. PE ratio of stock for trailing 12 months is 34.24, while it has posted earnings per share of $13.62 in the same period. Its PEG reads 3.96 and has Quick Ratio of 0.76 while making debt-to-equity ratio of 0.57. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for LIN, volatility over the week remained 1.95% while standing at 1.68% over the month.
Stock’s fiscal year EPS is expected to rise by 6.61% while it is estimated to increase by 9.71% in next year. EPS is likely to shrink at an annualized rate of 8.64% for next 5-years, compared to annual growth of 26.58% made by the stock over the past 5-years.
Coverage by Mizuho stated Linde Plc (LIN) stock as a Buy in their note to investors on April 18, 2024, suggesting a price target of $510 for the stock. On April 10, 2024, Citigroup Downgrade their recommendations, while on March 27, 2024, UBS Downgrade their ratings for the stock with a price target of $510. Stock get a Peer perform rating from Wolfe Research on March 01, 2024.
